Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Clinical Infectious Diseases

• Publication date

  2000-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/313864PMID 10875787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.

  1998cited by this paper
• Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guérin.

  1997cited by this paper
• Reliability of Tuberculin Skin Test Measurement

  1997cited by this paper
• Functional diversity of helper T lymphocytes

  1996cited by this paper
• Immune response to recombinant mycobacterial proteins in patients with tuberculosis infection and disease.

  1996cited by this paper
• Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection.

  1996cited by this paper
• A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection.

  1996cited by this paper
• Immune responses stimulated by percutaneous and intradermal bacille Calmette-Guérin.

  1996cited by this paper
• The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.

  1995cited by this paper
• Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.

  1994cited by this paper
• Experimental approaches to mechanisms of protection and pathogenesis in M. tuberculosis infection.

  1994cited by this paper
• Biological functions of IFN-gamma and IFN-alpha/beta: lessons from studies in gene knockout mice.

  1994cited by this paper
• Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls

  1994cited by this paper
• Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

  1994cited by this paper
• Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis BCG.

  1994cited by this paper
• Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature

  1994cited by this paper
• An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

  1993cited by this paper
• T cell response to Mycobacterium tuberculosis.

  1993cited by this paper
• Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection.

  1993cited by this paper
• Immunoreactivity of a 10-kDa antigen of Mycobacterium tuberculosis.

  1992cited by this paper
• Immunoassay of type IV collagenase/gelatinase (MMP-2) in human plasma.

  1992cited by this paper
• T lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens.

  1992cited by this paper
• Defining protective responses to pathogens: cytokine profiles in leprosy lesions.

  1991cited by this paper
• Defining protective responses to pathogens: cytokine profiles in leprosy lesions.

  1991cited by this paper
• Role of Cytokines and CD4+ T‐Cell Subsets in the Regulation of Parasite Immunity and Disease

  1989cited by this paper
• Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis.

  1987cited by this paper
• Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

  1986cited by this paper
• Materials and Methods Briefdefinitive Report Disseminated Tuberculosis in Interferon 7 Gene-disrupted Mice

  year unknowncited by this paper

• From Yesterday to Tomorrow: How Vaccine Platforms Have Shaped the Vaccine and Treatment Evaluation Units.

  2025cites this paper
• Immune responses of cattle vaccinated by various routes with Mycobacterium bovis Bacillus Calmette-Guérin (BCG)

  2025cites this paper
• Prevalence and Risk Factors of Latent Tuberculosis Infection Detected by IGRA in Patients with Immune-Mediated Inflammatory Diseases Before and During Biologic DMARD Therapy (TITAN Study)

  2025cites this paper
• Rethinking BCG vaccine delivery for enhanced efficacy: Are two distinct routes of BCG administration better than one?

  2025cites this paper
• Per Os to Protection - targeting the oral route to enhance immune-mediated protection from disease of the human newborn.

  2024cites this paper
• Immune mechanisms of granuloma formation in sarcoidosis and tuberculosis

  2024cites this paper
• Imprinting of Gut-Homing Receptors on Mtb-Specific Th1* Cells Is Associated with Reduced Lung Homing after Gavage BCG Vaccination of Rhesus Macaques

  2023cites this paper
• Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi

  2023cites this paper
• Distinct gene expression signatures comparing latent tuberculosis infection with different routes of Bacillus Calmette-Guérin vaccination

  2023cites this paper
• Stages of pregnancy and HIV affect diagnosis of tuberculosis infection and Mycobacterium tuberculosis (MTB)-induced immune response: Findings from PRACHITi, a cohort study in Pune, India

  2021cites this paper
• What is the evidence that mycobacteria are associated with the pathogenesis of Sjogren’s syndrome?

  2021influential citation
• Vaccines Against Tuberculosis: Problems and Prospects (Review)

  2020cites this paper
• Which sample type is better for Xpert MTB/RIF to diagnose adult and pediatric pulmonary tuberculosis?

  2020cites this paper
• Percutaneous BCG enhances innate effector antitumor cytotoxicity during treatment of bladder cancer: a translational clinical trial

  2019cites this paper
• The Humoral Immune Response to BCG Vaccination

  2019cites this paper
• Validation and Clinical Application of Interferon-Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection in Children

  2019cites this paper
• Comparison of TST and IGRA in Diagnosis of Latent Tuberculosis Infection in a High TB-Burden Setting

  2017cites this paper
• The Promise of New TB Vaccines

  2017cites this paper
• PO and ID BCG vaccination in humans induce distinct mucosal and systemic immune responses and CD4+ T cell transcriptomal molecular signatures

  2017cites this paper
• The Use of Interferon Gamma Inducible Protein 10 as a Potential Biomarker in the Diagnosis of Latent Tuberculosis Infection in Uganda

  2016cites this paper
• Mycobacterium bovis BCG and New Vaccines for the Prevention of Tuberculosis

  2016cites this paper
• Mucosal SIV Vaccines Comprising Inactivated Virus Particles and Bacterial Adjuvants Induce CD8+ T-Regulatory Cells that Suppress SIV-Positive CD4+ T-Cell Activation and Prevent SIV Infection in the Macaque Model

  2014cites this paper
• The ID93 Tuberculosis Vaccine Candidate Does Not Induce Sensitivity to Purified Protein Derivative

  2014cites this paper
• Investigations of TB vaccine-induced mucosal protection in mice.

  2014cites this paper
• Oral bacillus Calmette-Guérin vaccine against tuberculosis: why not?

  2014cites this paper
• Lactobacilli as live vectors for oral vaccination against TB

  2014cites this paper
• Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis.

  2014cites this paper
• Preparation of ESAT-6 Nanoparticles and Evaluation of Humoral Immunity after Intranasal Administration

  2013cites this paper
• Immune approaches in tuberculosis therapy: a brief

  2012cites this paper
• Prime–boost approaches to tuberculosis vaccine development

  2012cites this paper
• Oral Vaccination with Lipid-Formulated BCG Induces a Long-lived, Multifunctional CD4+ T Cell Memory Immune Response

  2012cites this paper
• Vaccines Against Mycobacterium tuberculosis: An Overview from Preclinical Animal Studies to the Clinic

  2012cites this paper
• Immune approaches in tuberculosis therapy: a brief overview

  2012cites this paper
• Mycobacterium bovis BCG and New Vaccines against Tuberculosis

  2011cites this paper
• Tuberculosis vaccines in clinical trials

  2011cites this paper
• The α4β1 integrin in localization of Mycobacterium tuberculosis-specific T helper type 1 cells to the human lung.

  2011cites this paper
• Low oral BCG doses fail to protect cattle against an experimental challenge with Mycobacterium bovis.

  2011cites this paper
• New vaccines against tuberculosis: lessons learned from BCG immunisation in Brazil.

  2008cites this paper
• BCG Vaccination: Epidemiology and Immunology

  2008cites this paper
• Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.

  2008cites this paper
• Tuberculosis vaccine development: goals, immunological design, and evaluation.

  2008cites this paper
• Immunogenicity of orally-delivered lipid-formulated BCG vaccines and protection against Mycobacterium tuberculosis infection.

  2008cites this paper
• Oral vaccination against bovine tuberculosis with Mycobacterium bovis BCG

  2007cites this paper
• Oral administration of BCG encapsulated in alginate microspheres induces strong Th1 response in BALB/c mice.

  2007cites this paper
• Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guérin vaccine 1 4

  2007cites this paper
• Extended Culture Enhances Sensitivity of a Gamma Interferon Assay for Latent Mycobacterium tuberculosis Infection

  2007cites this paper
• Rapid Diagnosis of Smear-Negative Tuberculosis Using Immunology and Microbiology with Induced Sputum in HIV-Infected and Uninfected Individuals

  2007cites this paper
• Effect of high-dose vitamin A supplementation on the immune response to Bacille Calmette-Guerin vaccine.

  2007cites this paper
• Bronchoscopic challenge with PPD results in development of localized lymphocytic inflammation in challenged BAL segments

  2007cites this paper
• Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis.

  2006cites this paper
• Progress in the development of tuberculosis vaccines for cattle and wildlife.

  2006cites this paper
• An In-House RD 1-Based Enzyme-Linked Immunospot – Gamma Interferon Assay Instead of the Tuberculin Skin Test for Diagnosis of Latent Mycobacterium tuberculosis Infection

  2006influential citation
• Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.

  2006cites this paper
• Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not.

  2006cites this paper
• Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.

  2006cites this paper
• Surprisingly High Specificity of the PPD Skin Test for M. tuberculosis Infection from Recent Exposure in The Gambia

  2006cites this paper
• Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users.

  2006cites this paper
• An In-House RD1-Based Enzyme-Linked Immunospot-Gamma Interferon Assay Instead of the Tuberculin Skin Test for Diagnosis of Latent Mycobacterium tuberculosis Infection

  2006cites this paper
• Oral vaccination of mice with lipid‐encapsulated Mycobacterium bovis BCG: Anatomical sites of bacterial replication and immune activity

  2005cites this paper
• Tuberculosis vaccine development; from mouse to man.

  2005cites this paper
• Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model.

  2005cites this paper
• Oral vaccination of brushtail possums (Trichosurus vulpecula) with BCG: immune responses, persistence of BCG in lymphoid organs and excretion in faeces

  2005cites this paper
• Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis.

  2005cites this paper
• Mice Fed Lipid-Encapsulated Mycobacterium bovis BCG Are Protected against Aerosol Challenge with Mycobacterium tuberculosis

  2005cites this paper
• Influence of oral cavity and gastrointestinal tract environment on Der p2-rBCG biological behavior

  2005cites this paper
• Strategies to improve BCG-mediated protection from Mycobacterium tuberculosis

  2004cites this paper
• BCG and New Tuberculosis Vaccines

  2004cites this paper
• Single Mucosal, but Not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis1

  2004cites this paper
• Single Intranasal Mucosal Mycobacterium bovis BCG Vaccination Confers Improved Protection Compared to Subcutaneous Vaccination against Pulmonary Tuberculosis

  2004cites this paper
• Protection from Pulmonary Tuberculosis Adenoviral-Based Vaccine Provides Potent Immunization with Recombinant Single Mucosal , but Not Parenteral ,

  2004cites this paper
• Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia.

  2004cites this paper
• Immune biology of macaque lymphocyte populations during mycobacterial infection

  2003cites this paper
• Recruitment of antigen-specific Th1-like responses to the human lung following bronchoscopic segmental challenge with purified protein derivative of Mycobacterium tuberculosis.

  2003cites this paper
• Lipoarabinomannan-reactive human secretory immunoglobulin A responses induced by mucosal bacille Calmette-Guérin vaccination.

  2003cites this paper
• Tuberculosis vaccines: the past, present and future

  2002cites this paper
• Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations.

  2002cites this paper
• New vaccines for the prevention of tuberculosis.

  2002cites this paper
• What's new in tuberculosis vaccines?

  2002cites this paper
• Dynamics of Gamma Interferon, Interleukin-12 (IL-12), IL-10, and Transforming Growth Factor β mRNA Expression in Primary Mycobacterium bovis BCG Infection in Guinea Pigs Measured by a Real-Time Fluorogenic Reverse Transcription-PCR Assay

  2002cites this paper
• Oral recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing HIV-1 antigens as a freeze-dried vaccine induces long-term, HIV-specific mucosal and systemic immunity.

  2002cites this paper
• The hunt for new tuberculosis vaccines: anti-TB immunity and rational design of vaccines.

  2001cites this paper